Institutional investors purchased a net $648.9 thousand shares of BGMD during the quarter ended September 2014 and now own 10.58% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE CALIFORNIA PUBLIC EMPLOYEES ... Bought 375.0 Thousand shares of BG Medicine Inc
FRIGATE VENTURES LP Bought 185.6 Thousand shares of BG Medicine Inc
BESSEMER INVESTMENT MANAGEMENT L... Bought 141.4 Thousand shares of BG Medicine Inc